KDM2A and lung cancer: We identified and validated a set of novel druggable non-oncogene vulnerabilities preferentially related to different lung cancer histotypes; dependency on KDM2A is associated with AD and SCLC, dependency on CSNK1A1 is associated with AD, and dependency on LTB4R2 is associated with SCC.